Leptin regulates parathyroid hormone secretion through CaSR ‐ ERK1 /2 signaling
The FASEB Journal · 2025
DOI: 10.1096/fj.202403141r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Rachel Kilav-Levin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Minerva Center for Bone and Mineral Research, Nephrology Services, Hadassah Hebrew University Medical Center, Jerusalem, Israel. Hauptthemen laut MEDLINE: Parathyroid Hormone, Receptors, Calcium-Sensing, Leptin, MAP Kinase Signaling System. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Israel Science Foundation (ISF), United States-Israel Binational Science Foundation (BSF).
Abstract (Originalsprache)
Leptin and parathyroid hormone (PTH) are key regulators of metabolic and mineral homeostasis. Leptin, primarily secreted by adipose tissue, controls appetite and energy expenditure through its receptors in the central nervous system, while PTH maintains serum calcium and phosphate balance and skeletal integrity by acting on kidneys and bone. The calcium sensing receptor (CaSR) plays a central role in parathyroid function and PTH secretion. While clinical and experimental evidence suggests reciprocal interactions between leptin and PTH, where hyperleptinemia and disrupted leptin signaling in obesity may exacerbate conditions such as secondary hyperparathyroidism, direct effects of leptin on the parathyroid remain poorly defined. We now show that leptin receptor‐deficient db/db mice exhibit reduced serum PTH levels at 4 and 7 months of age. Complementary ex vivo experiments in cultured mouse parathyroid glands demonstrate that recombinant leptin increases PTH secretion while downregulating CaSR and c‐fos gene expression. Furthermore, CaSR activation using a calcimimetic drug attenuated leptin's stimulatory effect on PTH secretion, indicating that leptin enhances PTH release by down regulating CaSR activity. These findings establish a direct regulatory link between leptin and PTH, highlighting leptin's role in modulating CaSR activity in the parathyroid. By counteracting CaSR‐mediated inhibition, leptin may prevent excessive suppression of PTH release by the CaSR. Clinically, these insights may hold implications for conditions such as hyperleptinemia, obesity, and other disorders of PTH dysregulation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Minerva Center for Bone and Mineral Research, Nephrology Services, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- Faculty of Life and Health Sciences, School of Nursing, Jerusalem College of Technology, Jerusalem, Israel.
- Faculty of Medicine, Endocrinology, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
- Wohl Institute for Translational Medicine, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
ORCID-Profile: Rachel Kilav-Levin, Alia Hassan, Danielle Melloul, Tally Naveh-Many
Förderung
- Israel Science Foundation (ISF)
- United States-Israel Binational Science Foundation (BSF)
Zitieren
APA
Kilav-Levin, R., Hassan, A., Melloul, D., & Naveh-Many, T. (2025). Leptin regulates parathyroid hormone secretion through CaSR ‐ ERK1 /2 signaling. The FASEB Journal. https://doi.org/10.1096/fj.202403141r
Vancouver
Kilav-Levin R, Hassan A, Melloul D, Naveh-Many T. Leptin regulates parathyroid hormone secretion through CaSR ‐ ERK1 /2 signaling. The FASEB Journal. 2025. doi:10.1096/fj.202403141r
BibTeX
@article{KilavLevin2025,
author = {Kilav-Levin, Rachel and Hassan, Alia and Melloul, Danielle and Naveh-Many, Tally},
title = {Leptin regulates parathyroid hormone secretion through CaSR ‐ ERK1 /2 signaling},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202403141r}
}
EUVIMED